The “edge effect” phenomenon: deriving population abundance patterns from individual animal movement decisions

Edge effects have been observed in a vast spectrum of animal populations. They occur where two conjoining habitats interact to create ecological phenomena that are not present in either habitat separately. On the individual-level, an edge effect is a change in behavioral tendency on or near the edge. On the population-level, it is a pattern of population abundance near an edge that cannot be explained in terms of either habitat in isolation. That these two levels of description exist suggests there ought to be a mathematical link between them. Here, we make inroads into providing such a link, deriving analytic expressions describing oft-observed population abundance patterns from a model of movement decisions near edges. Depending on the model parameters, we can see positive, negative, or transitional edge effects emerge. Importantly, the distance over which animals make their decisions to move between habitats turns out to be a key factor in quantifying the magnitude of certain observed edge effects

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

On parametric fragmentation measures

In the landscape ecological literature, a number of measures have been proposed for quantifying landscape fragmentation based on distinct objectives and motivations. However, none seems to be generally preferred. The main reason for this disagreement is that, from a statistical viewpoint, by mapping fragmentation into a single scalar, information is necessarily lost and no ideal function is able to uniquely characterize all aspects of landscape fragmentation. A more complete summarization of fragmentation is possible if, instead of one single index, a parametric index family is applied whose members have varying sensitivities to the presence of large and small landscape patches. While traditional indices supply point descriptions of fragmentation, according to a parametric fragmentation family Ha, there is a continuum of possible fragmentation measures that differ in their sensitivity to the presence of large and small patches as a function of the scaling parameter a. Therefore, changing a allows for vector description of fragmentation. The purpose of this paper is to introduce a parametric generalization of Shannon’s entropy to summarize landscape fragmentation. A small set of artificial landscapes is used to clarify our proposal